Rare
lephants
Screener
Toggle theme
Genmab A/S
GNMSF
·
Healthcare, Drug Manufacturers - General, Denmark
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
EPS
Sales Per Share
Book Per Share
FCF Per Share
Dividend Per Share
Shares Outstanding
Share-Based Metrics
›
EPS
Compare
←
5Y
10Y
MAX
→
EPS
Chart
Table
EPS
Cyclically Adjusted EPS
Fiscal Year
EPS
Cyclically Adjusted EPS
FY2023
$9.58
$9.86
FY2024
$17.53
$13.70
FY2025
$15.37
$14.25
Download CSV
